Ramona M. Absmeier

Multimeric ACE2-IgM fusions as broadly active antivirals that potently neutralize SARS-CoV-2 variants

J. Buchner, U. Protzer, Hristo L. Svilenov, 2022, Communications Biology.

Molecular mechanism of amyloidogenic mutations in hypervariable regions of antibody light chains

M. Zacharias, J. Buchner, M. Hitzenberger, 2021, The Journal of biological chemistry.

Dissection of the amyloid formation pathway in AL amyloidosis

H. Engelhardt, J. Buchner, P. Kazman, 2021, Nature Communications.

Antibodies gone bad – the molecular mechanism of light chain amyloidosis

J. Buchner, Hristo L. Svilenov, P. Kazman, 2022, The FEBS journal.

A constant domain mutation in a patient-derived antibody light chain reveals principles of AL amyloidosis

J. Buchner, M. Zacharias, L. Meier, 2023, Communications Biology.

Tailored Pyridoxal Probes Unravel Novel Cofactor‐Dependent Targets and Antibiotic Hits in Critical Bacterial Pathogens

S. Sieber, Martin Pfanzelt, Ramona M. Absmeier, 2022, Angewandte Chemie.